Integrin-β4 is a novel transcriptional target of TAp73

References

• Melino G, De Laurenzi V, Vousden KH. p73: Friend or foe in tumorigenesis. Nat Rev Cancer. 2002;2(8):605–615. doi:10.1038/nrc861. PMID:12154353
   PubMed Web of Science ®Google Scholar
• Lee P, Hock AK, Vousden KH, et al. p53- and p73-independent activation of TIGAR expression in vivo. Cell Death Dis. 2015;6:e1842. doi:10.1038/cddis.2015.205. PMID:26247727
   PubMed Web of Science ®Google Scholar
• Chillemi G, Kehrloesser S, Bernassola F, et al. Structural evolution and dynamics of the p53 proteins. Cold Spring Harb Perspect Med. 2017;7(4). doi:10.1101/cshperspect.a028308. PMID:27091942
   PubMed Web of Science ®Google Scholar
• Tomasini R, Mak TW, Melino G. The impact of p53 and p73 on aneuploidy and cancer. Trends Cell Biol. 2008;18(5):244–252. doi:10.1016/j.tcb.2008.03.003. PMID:18406616
   PubMed Web of Science ®Google Scholar
• Velletri T, Xie N, Wang Y, et al. P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development. Cell Death Dis. 2016;7:e2015. doi:10.1038/cddis.2015.367. PMID:26775693
   PubMed Web of Science ®Google Scholar
• Billant O, Léon A, Le Guellec S, et al. The dominant-negative interplay between p53, p63 and p73: A family affair. Oncotarget. 2016;7(43):69549–69564.
   PubMedGoogle Scholar
• Basu S, Murphy ME. p53 family members regulate cancer stem cells. Cell Cycle. 2016;15(11):1403–1404. doi:10.1080/15384101.2016.1171649. PMID:27057793
   PubMed Web of Science ®Google Scholar
• Gebel J, Luh LM, Coutandin D, et al. Mechanism of TAp73 inhibition by DeltaNp63 and structural basis of p63/p73 hetero-tetramerization. Cell Death Differ. 2016;23(12):1930–1940. doi:10.1038/cdd.2016.83. PMID:27716744
   PubMed Web of Science ®Google Scholar
• Slatter TL, Hung N, Bowie S, et al. Delta122p53, a mouse model of Delta133p53alpha, enhances the tumor-suppressor activities of an attenuated p53 mutant. Cell Death Dis. 2015;6:e1783. doi:10.1038/cddis.2015.149. PMID:26068791
   PubMed Web of Science ®Google Scholar
• Robbins D, Bakke J, Cherian MT, et al. PXR interaction with p53: a meeting of two masters. Cell Death Dis. 2016;7:e2218. doi:10.1038/cddis.2016.122. PMID:27148691
   PubMed Web of Science ®Google Scholar
• Celardo I, Grespi F, Antonov A, et al. Caspase-1 is a novel target of p63 in tumor suppression. Cell Death Dis. 2013;4:e645. doi:10.1038/cddis.2013.175. PMID:23703390
   PubMed Web of Science ®Google Scholar
• Rufini A, Agostini M, Grespi F, et al. p73 in Cancer. Genes Cancer. 2011;2(4):491–502. doi:10.1177/1947601911408890. PMID:21779517
   PubMedGoogle Scholar
• Thakur AK, Nigri J, Lac S, et al. TAp73 loss favors Smad-independent TGF-beta signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death Differ. 2016;23(8):1358–1370. doi:10.1038/cdd.2016.18. PMID:26943320
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhang J, Yan W, et al. p73 expression is regulated by ribosomal protein RPL26 through mRNA translation and protein stability. Oncotarget. 2016;7(48):78255–78268. PMID:27825141
   PubMedGoogle Scholar
• Landre V, Antonov A, Knight R, et al. p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression. Oncotarget. 2016;7(11):11785–11802. doi:10.18632/oncotarget.7600. PMID:26930720
   PubMedGoogle Scholar
• Petrova V, Mancini M, Agostini M, et al. TAp73 transcriptionally represses BNIP3 expression. Cell Cycle. 2015;14(15):2484–2493. doi:10.1080/15384101.2015.1044178. PMID:25950386
   PubMed Web of Science ®Google Scholar
• Amelio I, Inoue S, Markert EK, et al. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1alpha degradation. Proc Natl Acad Sci U S A 2015;112(1):226–231. doi:10.1073/pnas.1410609111. PMID:25535359
   PubMed Web of Science ®Google Scholar
• Agostini M, Tucci P, Killick R, et al. Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci U S A, 2011;108(52):21093–21098. doi:10.1073/pnas.1112061109. PMID:22160687
   PubMed Web of Science ®Google Scholar
• Agostini M, Romeo F, Inoue S, et al. Metabolic reprogramming during neuronal differentiation. Cell Death Differ. 2016;23(9):1502–1514. doi:10.1038/cdd.2016.36. PMID:27058317
   PubMed Web of Science ®Google Scholar
• Niklison-Chirou MV, Killick R, Knight RA, et al. How does p73 cause neuronal defects? Mol Neurobiol. 2016;53(7):4509–4520. doi:10.1007/s12035-015-9381-1. PMID:26266644
   PubMed Web of Science ®Google Scholar
• Turnquist C, Horikawa I, Foran E, et al. p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration. Cell Death Differ. 2016;23(9):1515–1528. doi:10.1038/cdd.2016.37. PMID:27104929
   PubMed Web of Science ®Google Scholar
• Vargas L, Alvarez A. P73 and P63: The siblings that work together in neurodevelopment. Cell Cycle. 2015;14(23):3671–3672. doi:10.1080/15384101.2015.1112615. PMID:26514275
   PubMed Web of Science ®Google Scholar
• Shamseddine AA, Clarke CJ, Carroll B, et al. P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest. Cell Death Dis. 2015;6:e1947. doi:10.1038/cddis.2015.268. PMID:26512957
   PubMed Web of Science ®Google Scholar
• Guadagno J, Swan P, Shaikh R, et al. Microglia-derived IL-1beta triggers p53-mediated cell cycle arrest and apoptosis in neural precursor cells. Cell Death Dis. 2015;6:e1779. doi:10.1038/cddis.2015.151. PMID:26043079
   PubMed Web of Science ®Google Scholar
• Amelio I, Markert EK, Rufini A, et al. p73 regulates serine biosynthesis in cancer. Oncogene. 2014;33(42):5039–5046. doi:10.1038/onc.2013.456. PMID:24186203
   PubMed Web of Science ®Google Scholar
• Amelio I, Antonov AA, Catani MV, et al. TAp73 promotes anabolism. Oncotarget, 2014;5(24):12820–12934. doi:10.18632/oncotarget.2667. PMID:25514460
   PubMedGoogle Scholar
• Du W, Jiang P, Mancuso A, et al. TAp73 enhances the pentose phosphate pathway and supports cell proliferation. Nat Cell Biol. 2013;15(8):991–1000. doi:10.1038/ncb2789. PMID:23811687
   PubMed Web of Science ®Google Scholar
• Amelio I, Cutruzzolá F, Antonov A, et al. Serine and glycine metabolism in cancer. Trends Biochem Sci. 2014;39(4):191–198. doi:10.1016/j.tibs.2014.02.004. PMID:24657017
   PubMed Web of Science ®Google Scholar
• Agostini M, Annicchiarico-Petruzzelli M, Melino G, et al. Metabolic pathways regulated by TAp73 in response to oxidative stress. Oncotarget. 2016;7(21):29881–2900. doi:10.18632/oncotarget.8935. PMID:27119504
   PubMedGoogle Scholar
• Teoh PJ, Bi C, Sintosebastian C, et al. PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylation. Oncotarget. 2016;7(38):61806–61819. doi:10.18632/oncotarget.11241. PMID:27533450
   PubMedGoogle Scholar
• Velletri T, Romeo F, Tucci P, et al. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation. Cell Cycle. 2015;14(10):1611–1612. PMID:25997017
   PubMed Web of Science ®Google Scholar
• Rufini A, Niklison-Chirou MV, Inoue S, et al., TAp73 depletion accelerates aging through metabolic dysregulation. Genes Dev. 2012;26(18):2009–2014. doi:10.1101/gad.197640.112. PMID:22987635
   PubMed Web of Science ®Google Scholar
• Sharif T, Ahn D-G, Liu RZ, et al. The NAD(+) salvage pathway modulates cancer cell viability via p73. Cell Death Differ. 2016;23(4):669–680. doi:10.1038/cdd.2015.134. PMID:26586573
   PubMed Web of Science ®Google Scholar
• Inoue S, Tomasini R, Rufini A, et al. TAp73 is required for spermatogenesis and the maintenance of male fertility. Proc Natl Acad Sci U S A. 2014;111(5):1843–1848. doi:10.1073/pnas.1323416111. PMID:24449892
   PubMed Web of Science ®Google Scholar
• Holembowski L, Kramer D, Riedel D, et al. TAp73 is essential for germ cell adhesion and maturation in testis. J Cell Biol. 2014;204(7):1173–1190. doi:10.1083/jcb.201306066. PMID:24662569
   PubMed Web of Science ®Google Scholar
• Tomasini R, Tsuchihara K, Wilhelm M, et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev. 2008;22(19):2677–2691. doi:10.1101/gad.1695308. PMID:18805989
   PubMed Web of Science ®Google Scholar
• Moindjie H, Santos ED, Gouesse R-J, et al. Preimplantation factor is an anti-apoptotic effector in human trophoblasts involving p53 signaling pathway. Cell Death Dis. 2016;7(12):e2504. doi:10.1038/cddis.2016.382. PMID:27906186
   PubMed Web of Science ®Google Scholar
• Case LB, Waterman CM. Integration of actin dynamics and cell adhesion by a three-dimensional, mechanosensitive molecular clutch. Nat Cell Biol. 2015;17(8):955–963. PMID:26121555
   PubMed Web of Science ®Google Scholar
• Jacquemet G, Humphries MJ, Caswell PT. Role of adhesion receptor trafficking in 3D cell migration. Curr Opin Cell Biol. 2013;25(5):627–632. doi:10.1016/j.ceb.2013.05.008. PMID:23797030
   PubMed Web of Science ®Google Scholar
• Woo JA, Zhoa X, Khan H, et al. Slingshot-Cofilin activation mediates mitochondrial and synaptic dysfunction via Abeta ligation to beta1-integrin conformers. Cell Death Differ. 2015;22(6):921–934. doi:10.1038/cdd.2015.5. PMID:25698445
   PubMed Web of Science ®Google Scholar
• Huang S, Ingber DE. Cell tension, matrix mechanics, and cancer development. Cancer Cell. 2005;8(3):175–176. doi:10.1016/j.ccr.2005.08.009. PMID:16169461
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang X, Pang N, et al. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-alphavbeta3 integrin cross-talk. Cell Death Dis. 2015;6:e1796. doi:10.1038/cddis.2015.174. PMID:26111058
   PubMed Web of Science ®Google Scholar
• Xiao T, Takagi J, Coller BS, et al. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature. 2004;432(7013):59–67. doi:10.1038/nature02976. PMID:15378069
   PubMed Web of Science ®Google Scholar
• Seguin L, Desgrosellier JS, Weis SM, et al. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 2015;25(4):234–240. doi:10.1016/j.tcb.2014.12.006. PMID:25572304
   PubMed Web of Science ®Google Scholar
• Bierie B, Pierce SE, Kroeger C, et al. Integrin-beta4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc Natl Acad Sci U S A. 2017;114(12):E2337–E2346. doi:10.1073/pnas.1618298114. PMID:28270621
   PubMed Web of Science ®Google Scholar
• Zheng Y, de la Cruz CC, Sayles LC, et al. A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal. Cancer Cell. 2013;24(1):59–74. doi:10.1016/j.ccr.2013.05.021. PMID:23845442
   PubMed Web of Science ®Google Scholar
• Wang H, Rana S, Giese N, et al. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells. Int J Cancer. 2013;133(2):416–426. doi:10.1002/ijc.28044. PMID:23338841
   PubMed Web of Science ®Google Scholar
• Banyard J, Chung I, Migliozzi M, et al. Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer. BMC Cancer. 2014;14:387. doi:10.1186/1471-2407-14-387. PMID:24885350
   PubMed Web of Science ®Google Scholar
• Nagata M, Noman AA, Suzuki K, et al. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma. BMC Cancer. 2013;13:410. doi:10.1186/1471-2407-13-410. PMID:24006899
   PubMed Web of Science ®Google Scholar
• Stewart RL, O'Connor KL. Clinical significance of the integrin [alpha]6[beta]4 in human malignancies. Lab Invest. 2015;95(9):976–986. doi:10.1038/labinvest.2015.82. PMID:26121317
   PubMed Web of Science ®Google Scholar
• Toh WH, Logette E, Corcos L, et al. TAp73beta and DNp73beta activate the expression of the pro-survival caspase-2S. Nucleic Acids Res. 2008;36(13):4498–509. doi:10.1093/nar/gkn414. PMID:18611950
   PubMed Web of Science ®Google Scholar
• Vikhanskaya F, Toh WH, Dulloo I, et al. p73 supports cellular growth through c-Jun-dependent AP-1 transactivation. Nat Cell Biol. 2007;9(6):698–705. doi:10.1038/ncb1598. PMID:17496887
   PubMed Web of Science ®Google Scholar
• Koeppel M, van Heeringen SJ, Kramer D, et al. Crosstalk between c-Jun and TAp73alpha/beta contributes to the apoptosis-survival balance. Nucleic Acids Res. 2011;39(14):6069–6085. doi:10.1093/nar/gkr028. PMID:21459846
   PubMed Web of Science ®Google Scholar
• Dulloo I, Phang BH, Othman R, et al. Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptome. Nat Cell Biol. 2015;17(4):511–523. doi:10.1038/ncb3130. PMID:25774835
   PubMed Web of Science ®Google Scholar
• Bachelder RE, Marchetti A, Falcioni R, et al. Activation of p53 Function in Carcinoma Cells by the α6β4 Integrin. J Biol Chem. 1999;274(29):20733–20737. doi:10.1074/jbc.274.29.20733. PMID:10400708
   PubMed Web of Science ®Google Scholar
• Bachelder RE, Ribick MJ, Marchetti A, et al. P53 inhibits α6β4 integrin survival signaling by promoting the caspase 3–dependent cleavage of Akt/PKB. J Cell Biol.P 1999;147(5):1063–1072. doi:10.1083/jcb.147.5.1063. PMID:10579725
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim JM, Kim KH et al. Genotoxic stress/p53-induced DNAJB9 inhibits the pro-apoptotic function of p53. Cell Death Differ. 2015;22(1):86–95. doi:10.1038/cdd.2014.116. PMID:25146923
   PubMed Web of Science ®Google Scholar
• Alsafadi S, Tourpin S, Bessoltane N, et al. Nuclear localization of the caspase-3-cleaved form of p73 in anoikis. Oncotarget 2016;7(11):12331–1243. doi:10.18632/oncotarget.6329. PMID:26575022
   PubMedGoogle Scholar
• Renner G, Janouskova H, Noulet F, et al. Integrin alpha5beta1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma. Cell Death Differ. 2016;23(4):640–653. doi:10.1038/cdd.2015.131. PMID:26470725
   PubMed Web of Science ®Google Scholar
• Muller PA, Caswell PT, Doyle B, et al. Mutant p53 drives invasion by promoting integrin recycling. Cell. 2009;139(7):1327–1341. doi:10.1016/j.cell.2009.11.026. PMID:20064378
   PubMed Web of Science ®Google Scholar
• Kehrloesser S, Osterburg C, Tuppi M, et al. Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family. Cell Death Differ. 2016;23(12):1952–1960. doi:10.1038/cdd.2016.75. PMID:27447112
   PubMed Web of Science ®Google Scholar
• Alam SK, Yadav VK, Bajaj S, et al., DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53. Cell Death Differ. 2016;23(4):707–722. doi:10.1038/cdd.2015.133. PMID:26494468
   PubMed Web of Science ®Google Scholar
• Lee JG, Ahn J-H, Kim TJ, et al. Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin beta4 and Akt signals. Sci Rep. 2015;5:12642. doi:10.1038/srep12642. PMID:26223322
   PubMed Web of Science ®Google Scholar
• Tan BS, Tiong KH, Choo HL, et al. Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF). Cell Death Dis. 2015;6:e1826. doi:10.1038/cddis.2015.191. PMID:26181206
   PubMed Web of Science ®Google Scholar
• Candi E, Cipollone R, Rivetti di Val Cervo P, et al. p63 in epithelial development. Cell Mol Life Sci. 2008;65(20):3126–3133. doi:10.1007/s00018-008-8119-x. PMID:18560758
   PubMed Web of Science ®Google Scholar
• Vanbokhoven H, Melino G, Candi E, et al., p63, a story of mice and men. J Invest Dermatol. 2011;131(6):1196–1207. doi:10.1038/jid.2011.84. PMID:21471985
   PubMed Web of Science ®Google Scholar
• Lena AM, Cipollone R, Amelio I, et al. Skn-1a/Oct-11 and DeltaNp63alpha exert antagonizing effects on human keratin expression. Biochem Biophys Res Commun. 2010;401(4):568–573. doi:10.1016/j.bbrc.2010.09.102. PMID:20888799
   PubMed Web of Science ®Google Scholar
• Novelli F, Lena AM, Panatta E, et al. Allele-specific silencing of EEC p63 mutant R304W restores p63 transcriptional activity. Cell Death Dis. 2016;7:e2227. doi:10.1038/cddis.2016.118. PMID:27195674
   PubMed Web of Science ®Google Scholar
• Cam M, Gardner HL, Roberts RD, et al. DeltaNp63 mediates cellular survival and metastasis in canine osteosarcoma. Oncotarget. 2016;7(30):48533–48546. doi:10.18632/oncotarget.10406. PMID:27391430
   PubMedGoogle Scholar
• Rizzo JM, Oyelakin A, Min S, et al. DeltaNp63 regulates IL-33 and IL-31 signaling in atopic dermatitis. Cell Death Differ. 2016;23(6):1073–1085. doi:10.1038/cdd.2015.162. PMID:26768665
   PubMed Web of Science ®Google Scholar
• Carroll DK, Carroll JS, Leong C-O, et al. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol. 2006;8(6):551–561. doi:10.1038/ncb1420. PMID:16715076
   PubMed Web of Science ®Google Scholar
• Wang L, Dong ZW, Zhang Y, et al. The roles of integrin beta4 in vascular endothelial cells. J Cell Physiol. 2012;227(2):474–478. doi:10.1002/jcp.22769. PMID:21465468
   PubMed Web of Science ®Google Scholar
• Venkatanarayan A, Raulji P, Norton W, et al. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73. Cell Cycle. 2016;15(2):164–171. doi:10.1080/15384101.2015.1121333. PMID:26652033
   PubMed Web of Science ®Google Scholar
• Di C, Sun C, Li H, et al., Diallyl disulfide enhances carbon ion beams-induced apoptotic cell death in cervical cancer cells through regulating Tap73 /DeltaNp73. Cell Cycle. 2015;14(23):3725–3733. doi:10.1080/15384101.2015.1104438. PMID:26505313
   PubMed Web of Science ®Google Scholar
• Belle JI, Petrov JC, Langlais D, et al. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance. Cell Death Differ. 2016;23(5):759–775. doi:10.1038/cdd.2015.140. PMID:26768662
   PubMed Web of Science ®Google Scholar
• Le Pen J, Laurent M, Sarosiek K, et al. Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL. Cell Death Dis. 2016;7:e2083. doi:10.1038/cddis.2015.400. PMID:26844698
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang K, O'Neill KL, et al. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53. Cell Death Dis 2016;7:e2266. doi:10.1038/cddis.2016.167. PMID:27310874
   PubMed Web of Science ®Google Scholar